2013 AACR: Evaluation oral bioavailability and intermittent dosing schedule for PD effects by SGI-113 November 2013/in 2013, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products2013 AACR: Evaluation oral bioavailability and intermittent dosing schedule for PD effects by SGI-11 https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2013-11-03 16:34:312016-11-25 16:34:502013 AACR: Evaluation oral bioavailability and intermittent dosing schedule for PD effects by SGI-11
